Barrington raised the firm’s price target on Universal Technical (UTI) to $36 from $35 and keeps an Outperform rating on the shares after the company’s Q2 results came in above expectations and FY25 guidance was raised. The firm expects continued strong performance going forward, driven by Phase II of its North Star Strategy, which is expected to result in a five-year revenue compound annual growth rate of 10%, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTI: